نتائج البحث 1301-1310 من 4965 لعملية البحث عن Blood factor II
... factors in order to improve the ability to diagnose and treat these cancers. ... A second purpose of this study is to obtain blood ... This phase II trials studies ...
This is a Phase 2 global, multi-center, open-label study to assess the efficacy, safety and tolerability of AZD0486 monotherapy in adult participants with ...
... II dose (RP2D of APG2575 in combination with Pomalidomide/dexamethasone (Pd) in patients with relapsed/refractory (R/R) multiple myeloma (MM), or ...
Scottsdale/Phoenix, Ariz. This phase II trial tests whether an exercise intervention works to improve cognitive function in breast cancer survivors. Many breast ...
The purpose of this study is to develop prognostic and diagnostic blood ... We further examine whether blood biomarkers can ... 2-year progression free survival ( ...
... 2-year progression free survival (PFS) rate as compared to ACNS0122. Also ... factors and spared pathophysiological effects despite their genetic risk.
... 2 or 3 meningioma as measured by 6-month PFS rate. ... Finally, it will allow characterization of patient selection factors ... Finally, it will allow ...
This is an open label, phase I/II, multi-center study in adult participants with metastatic hormone sensitive prostate cancer (mHSPC) and with metastatic ...
The purpose of this study is to compare the effects, good and/or bad of two treatment methods on subjects and their cancer. Proton beam radiation therapy is one ...
prior chemotherapy or radiation exposure, cumulative radiotheranostic dose) with geneticclonal abnormalities (blood ... factors for developing hematological ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.